Analysed PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) News Sources
PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order
20-04-2026
yahoo.com
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
06-03-2026
yahoo.com
Pharmala Biotech Signs Supply and Data Agreement With Nautilus Sanctuary for Provision of MDMA for Use in Phase 2 Clinical Trial in U.S.
03-03-2026
yahoo.com
PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders
03-03-2026
yahoo.com
PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia
26-02-2026
yahoo.com
What is the current price of PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS)?
The current price of PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) is $0.1359.
PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) since the previous trading day is $0.064045.
PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) since the previous trading day is 89.1309%.
What is the most recent average sentiment score for PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS)?
The most recent average sentiment score for PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) is 78 out of 100.
What is the most recent average sentiment for PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS)?
The most recent sentiment for PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS) is .
SEC-8K** Filing Available For PHARMALA BIOTECH HOLDINGS IN (MDXXF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.